China’s Innovent holds potential to change pancreatic cancer treatment with bispecific antibody IBI389: GlobalData Read more
Moderna’s Covid-19/influenza vaccine phase III data highlights potential of mRNA technology for infectious diseases: GlobalData Read more
Amylyx’s efforts to explore other indications for Relyvrio seems to be bearing fruit: GlobalData Read more
TAGRISSO reduces disease progression or death by 84 % in Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial Read more